1997 U.S. Code
Title 21 - FOOD AND DRUGS
CHAPTER 20 - NATIONAL DRUG CONTROL PROGRAM
SUBCHAPTER I - OFFICE OF NATIONAL DRUG CONTROL POLICY
Sec. 1505 - Counter-Drug Technology Assessment Center
View Metadata| Publication Title | United States Code, 1994 Edition, Supplement 3, Title 21 - FOOD AND DRUGS |
| Category | Bills and Statutes |
| Collection | United States Code |
| SuDoc Class Number | Y 1.2/5: |
| Contained Within | Title 21 - FOOD AND DRUGS CHAPTER 20 - NATIONAL DRUG CONTROL PROGRAM SUBCHAPTER I - OFFICE OF NATIONAL DRUG CONTROL POLICY Sec. 1505 - Counter-Drug Technology Assessment Center |
| Contains | section 1505 |
| Date | 1997 |
| Laws in Effect as of Date | January 26, 1998 |
| Positive Law | No |
| Disposition | standard |
| Source Credit | Pub. L. 100-690, title I, §1008, formerly §1003A, as added Pub. L. 101-510, div. A, title X, §1011, Nov. 5, 1990, 104 Stat. 1633; renumbered §1008 and amended Pub. L. 103-322, title IX, §90204(a), (b), (c)(2), (3), Sept. 13, 1994, 108 Stat. 1993, 1994. |
| Statutes at Large References | 102 Stat. 4188 104 Stat. 1633 108 Stat. 1993 |
| Public Law References | Public Law 100-690, Public Law 101-510, Public Law 103-322 |
§1505. Counter-Drug Technology Assessment Center (a) Establishment
There is established within the Office of National Drug Control Policy, the Counter-Drug Technology Assessment Center (hereinafter in this section referred to as the “Center”). The Center shall operate under the authority of the Director of National Drug Control Policy and shall serve as the central counter-drug enforcement research and development organization of the United States Government.
(b) Chief ScientistThere shall be at the head of the Center the Chief Scientist of Counter-Drug Technology (hereinafter in this section referred to as the “Chief Scientist”). The Chief Scientist shall be appointed by the Director of National Drug Control Policy from among individuals qualified and distinguished in the area of science, engineering, or technology.
(c) Additional responsibilities of Director(1) The Director, acting through the Chief Scientist, shall—
(A) identify and define the short, medium, and long-term scientific and technological needs of Federal, State, and local drug enforcement agencies, including—
(i) advanced surveillance, tracking, and radar imaging;
(ii) electronic support measures;
(iii) communications;
(iv) data fusion, advanced computer systems and artificial intelligence; and
(v) chemical, biological, radiological (including neutron, electron, and graviton) and other means of detection;
(B) in consultation with the National Institute on Drug Abuse, and through interagency agreements or grants, examine addiction and rehabilitation research and the application of technology to expanding the effectiveness or availability of drug treatment;
(C) make a priority ranking of such needs according to fiscal and technological feasibility, as part of a National Counter-Drug Enforcement Research and Development Strategy;
(D) oversee and coordinate counter-drug technology initiatives with related activities of other Federal civilian and military departments; and
(E) under the general authority of the Director of National Drug Control Policy, submit requests to Congress for the reprogramming or transfer of funds appropriated for counter-drug enforcement research and development.
(2) The authority granted to the Director under this section shall not extend to the award of contracts, management of individual projects, or other operational activities.
(d) Counter-drug budget submissionBeginning with the budget submitted to Congress for fiscal year 1992 pursuant to section 1105 of title 31, the President shall submit a separate and detailed request relating to those Federal departments and agencies having responsibility for counter-drug enforcement research and development programs.
(e) PersonnelSubject to subsections (d) and (e) of section 1502 of this title, the Chief Scientist shall select and appoint a staff of not more than 10 employees with specialized experience in scientific, engineering, and technical affairs.
(f) Assistance and support to Office of National Drug Control PolicyThe Director of the Advanced Research Project Agency shall, to the fullest extent possible, render assistance and support to the Office of National Drug Control Policy and its Director.
(Pub. L. 100–690, title I, §1008, formerly §1003A, as added Pub. L. 101–510, div. A, title X, §1011, Nov. 5, 1990, 104 Stat. 1633; renumbered §1008 and amended Pub. L. 103–322, title IX, §90204(a), (b), (c)(2), (3), Sept. 13, 1994, 108 Stat. 1993, 1994.)
Repeal of SectionFor repeal of section on Sept. 30, 1997, see section 1506 of this title.
CodificationSection was formerly classified to section 1502a of this title prior to renumbering by Pub. L. 103–322.
Prior ProvisionsA prior section 1505, Pub. L. 100–690, title I, §1008, Nov. 18, 1988, 102 Stat. 4188, provided for an executive reorganization study and report to Congress and the President no later than Jan. 15, 1990, prior to repeal by Pub. L. 103–322, §90204(c)(1).
Amendments1994—Subsec. (c)(1)(B) to (E). Pub. L. 103–322, §90204(a), added subpar. (B) and redesignated former subpars. (B) to (D) as (C) to (E), respectively.
Subsec. (f). Pub. L. 103–322, §90204(b), added subsec. (f).
Disclaimer: These codes may not be the most recent version. The United States Government Printing Office may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the U.S. site. Please check official sources.